cN0期甲状腺乳头状癌中央区淋巴结转移的危险因素分析

摘要
图/表
参考文献
相关文章 (15)

全文: PDF (688 KB)
输出: BibTeX | EndNote (RIS)

摘要目的探讨cN0期甲状腺乳头状癌患者中央区淋巴结转移相关危险因素。方法纳入北京协和医院行双侧中央区淋巴结清扫的cN0期甲状腺乳头状癌患者570例,回顾性分析患者术前甲状腺超声图像及临床病理资料特征,分析预测cN0期甲状腺乳头状癌中央区淋巴结转移相关危险因素。结果 570例cN0期甲状腺乳头状癌患者中发生中央区淋巴结转移282例,占49.5%;其中男性(OR=1.787, 95% CI:1.066-2.997, P=0.028)、年龄小于45岁(OR=2.063, 95% CI:1.366-3.115, P=0.001)、多发病灶(OR=1.764, 95% CI:1.134-2.743, P=0.012)、肿瘤直径＞1 cm(OR=1.844, 95% CI:1.201-2.831, P=0.005)、伴有微钙化(OR=1.965, 95% CI:1.296-2.979, P=0.001)且有被膜侵犯(OR=2.868, 95% CI:1.880-4.377, P=0.000)是中央区淋巴结转移的独立危险因素。结论对于男性、年龄小于45岁、多发病灶、肿瘤直径＞1 cm、伴有微钙化且有被膜侵犯的cN0期甲状腺乳头状癌应根据影像学及临床病理资料考虑采取积极的手术方式或更加密切的随访。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	张雪鹤
	高璐滢
	赵瑞娜
	黄雪培
	刘睿峰
	史新龙
	夏宇

关键词 ：甲状腺乳头状癌, cN0, 淋巴结转移, 超声, 中央区淋巴结转移

Abstract：Objective To analyze the risk factors of central lymph node(CLN) metastasis in patients with cN0 stage papillary thyroid carcinoma(PTC).Methods: We retrospectively studied 570 patients with cN0 stage PTC who underwent bilateral CLN dissection in Peking Union Medical College Hospital from 2013 to 2015. CLN metastasis was identified by histopathology. Patients with different CLN metastasis statuses were compared according to clinical, sonographic and pathological parameters.Results The prevalence of CLN metastasis was 49.5% in cN0 patients with PTC. CLN metatasis was independent associated with Male(OR=1.787, 95% CI:1.066-2.997, P=0.028), <45 years old(OR=2.063, 95% CI:1.366-3.115, P=0.001), multifocal lesions (OR=1.764, 95% CI:1.134-2.743, P=0.012), tumor diameter(OR=1.844, 95% CI:1.201-2.831, P=0.005) >1 cm, microcalcification(OR=1.965, 95%,CI:1.296-2.979, P=0.001) and capsular invasion (OR=2.868, 95% CI:1.880-4.377, P=0.000) were independent risk factors.Conclusions The CLNM rates of PTC cN0 patients with the six factors (Male, <45 years old, multifocal lesions, tumor diameter>1 cm, microcalcification and capsular invasion) were relatively higher than those without. These findings may be useful for identifying patients at higher central lymph node metastasis risk, who may require more aggressive treatment or intensive follow-up management.

Key words： papillary thyroid carcinoma cN0 Lymph node metastasis ultrasound central Lymph node metastasis

收稿日期: 2020-12-01

ZTFLH:

R445.1

通讯作者: 夏宇,E-mail:yuxiapumch@aliyun.com

作者简介: 张雪鹤,硕士,主治医师。

引用本文:

张雪鹤, 高璐滢, 赵瑞娜, 黄雪培, 刘睿峰, 史新龙, 夏宇. cN0期甲状腺乳头状癌中央区淋巴结转移的危险因素分析[J]. 武警医学, 2021, 32(5): 407-410. ZHANG Xuehe, GAO Luying, ZHAO Ruina, HUANG Xuepei, LIU Ruifeng, SHI Xinlong, XIA Yu. Prediction of central lymph node metastasis in cN0 stage papillary thyroid carcinoma. Med. J. Chin. Peop. Armed Poli. Forc., 2021, 32(5): 407-410.

链接本文:

http://journal08.magtechjournal.com/Jwk_wjyx/CN/ 或 http://journal08.magtechjournal.com/Jwk_wjyx/CN/Y2021/V32/I5/407

[1]	Dai W C, Jiang B, Cheng W X, et al. The significance of lymph node dissection in the VI area of cN0 thyroid papillary carcinoma[J].J Clini Otorhinolaryngology, 2016, 30(4):319-321.
[2]	刘文,程若川,苏艳军,等.甲状腺乳头状癌中央区淋巴结转移危险因素研究(附3273例回顾性分析)[J].中国实用外科杂志,2018,38(3):316-321
[3]	Zhang L, Wang Y, Li X X, et al. Prophylactic central neck dissection versus traditional total thyroidectomy for stage cN0 papillary thyroid carcinoma: a meta-analysis[J]. Chin J of Bases and Clinics in General Surg, 2015, 22(12):1487-1494.
[4]	Haugen B R, Alexander E K, Bible K C, et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer [J]. Thyroid, 2016, 26(1): 1-133.
[5]	Khokhar M T, Day K M, Sangal R B, et al. Preoperative High-Resolution Ultrasound for the Assessment of Malignant Central Compartment Lymph Nodes in Papillary Thyroid Cancer[J]. Thyroid, 2015, 25(12):1351-1354.
[6]	中国超声医学工程学会浅表器官及外周血管专业委员会.甲状腺及相关颈部淋巴结超声若干临床常见问题专家共识(2018)[J].中国超声医学杂志,2019,35(3):193-204.
[7]	Oltmann S C, Schneider D F, Chen H , et al. All Thyroid Ultrasound Evaluations are Not Equal: Sonographers Specialized in Thyroid Cancer Correctly Label Clinical N0 Disease in Well Differentiated Thyroid Cancer[J]. Annals of Surg Oncology, 2015, 22(2):422-428
[8]	周瑾,周世崇,李佳伟,等.单灶性甲状腺乳头状癌中央区淋巴结转移危险因素分析[J].中华超声影像学杂志,2019,5(3):235-240.
[9]	武元元, 范向达, 王军, 等. cN0期甲状腺乳头状微小癌大容量中央区淋巴结转移的危险因素[J]. 中国普通外科杂志,2019, 28(11):59-64.
[10]	Wei S, Lan X, Zhang H, et al. Risk Factors for Central Lymph Node Metastasis in CN0 Papillary Thyroid Carcinoma: A Systematic Review and Meta-Analysis[J].Plos One, 2015, 10(10):e0139021.
[11]	王晓庆,魏玺,徐勇,等.甲状腺微小乳头状癌超声特征与颈部淋巴结跳跃性转移的相关性研究[J].中华肿瘤杂志,2019,41(5):373-377.
[12]	Huang X P, Ye T T, Zhang L, et al. Sonographic features of papillary thyroid microcarcinoma predicting high-volume central neck lymph node metastasis[J]. Surg Oncology, 2018, 27(2):172-176.
[13]	席镤,李红强,柳桢,等.甲状腺乳头状癌颈侧区淋巴结跳跃性转移危险因素分析[J].中国实用外科杂志,2020,40(12):86-89.
[14]	税春燕,李超,孙荣昊,等.甲状腺乳头状癌临床病理特征对颈部淋巴结转移风险预测[J].中华肿瘤防治杂志,2019,26(13):62-68.
[15]	谭学礼,刘轼初,钟晓玲,等.甲状腺微小乳头状癌中央区淋巴结转移复发相关因素研究分析[J].影像科学与光化学,2020,38(6):104-109.
[16]	张奥博,刘良发,路承,等. cN0期甲状腺乳头状癌患者颈部中央区淋巴结转移的危险因素分析[J]. 临床耳鼻咽喉头颈外科杂志, 2017, 31(15):1141-1145.
[17]	叶添添,杨筱,杨萌,等. 甲状腺微小乳头状癌原发病变超声特点与颈部大量淋巴结转移的相关性[J]. 中华医学超声杂志(电子版), 2017,14(10):760-765.
[18]	师帅,付言涛.cN0期甲状腺乳头状癌中央组淋巴结预防性清扫的研究进展[J].中国普通外科杂志,2020,29(11):98-106.
[19]	Amin M B, Edge S, Greene F, et al. 2017 AJCC Cancer Staging Manual[M]. Eighth ed. New York: Springer, 2017.
[20]	Zhang Z, Zhao S, Wang K, et al. Identification of biomarkers associated with cervical lymph node metastasis in papillary thyroid carcinoma: Evidence from an integrated bioinformatic analysis[J]. Clinical Hemorheology and Microcirculation, 2021,9(4):1-10.
[21]	李卫, Linwah Yip, 周剑宇,等. 多灶性甲状腺乳头状癌克隆起源分析[J]. 中国实用外科杂志, 2017,37(9):1024-1027.
[22]	赵淑艳, 程若川, 马云海,等. cN0 T1/T2期甲状腺乳头状癌中央区淋巴结转移规律的临床研究[J]. 中华内分泌外科杂志, 2019,28(4):283-288.
[23]	Lee Y C, Eun Y G, Sohn Y M, et al. Predictive factors for occult contralateral carcinoma in patients with unilateral papillary thyroid microcarcinoma by preoperative ultrasonographic and pathological features [J]. World J Surg, 2015, 39(7): 1736-1741.